Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00317811 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DIETARY_SUPPLEMENT: ascorbic acid
DRUG: bortezomib
DRUG: melphalan

Sponsor

Oncotherapeutics